← Leaderboards
Stacey S Cherny
Chinese University Of Hong Kong
$52,432
Attributed
$272,242
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $225.2K · FY2010–11$250K$187.5K$125K$62.5K$0
'10
'11
Funding mix
By agency
NIH$272,242 · 1
By mechanism
R21$272,242 · 1
Top collaborators
- Lawrence Baum3 shared
- Ding Ding3 shared
- Patrick Kwan3 shared
- Josemir W Sander3 shared
- Wenzhi Wang1 shared
Most similar at Chinese University Of Hong Kong
Same institution · by research overlap
- Ping Chung Leung$2,035,051
- Lawrence Baum$52,432
- Ding Ding$52,432
- Patrick Kwan$52,432
- Josemir W Sander$52,432
Others in their field
Top investigators on “Antiepileptic Agents”
- Daniel Lowenstein · Beth Israel Deaconess Medical Center$26,416,844
- Richard C. Mohs · Mount Sinai School Of Medicine Of Nyu$24,186,020
- Tracy A Glauser · Children'S Hospital Med Ctr (Cincinnati)$11,752,873
- Kimford J Meador · Medical College Of Georgia (Mcg)$11,524,420
- John R Huguenard · Stanford University$10,464,362
- Page Buckhannan Pennell · University Of Minnesota$9,597,847
Research focus
Antiepileptic AgentsAreaBaseBrainChinaChinese PeopleClassificationClinical Assessment ToolCohortCollaborationsCountryDeveloping CountriesDiagnosisDrug ResistanceEffective TherapyElectroencephalographyEmploymentEpilepsyEvaluationFederal GovernmentFollow-UpFrequencies (Time Pattern)GeneticAffect
Grant awards (3)
Validation of clinical assessment tools for population genetic studies of epileps$47,046
R21 · FY2011 · NS
Validation of clinical assessment tools for population genetic studies of epileps$164,716
R21 · FY2010 · NS
Validation of clinical assessment tools for population genetic studies of epileps$60,480
R21 · FY2010 · NS